pubmed-article:16096320 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16096320 | lifeskim:mentions | umls-concept:C0018483 | lld:lifeskim |
pubmed-article:16096320 | lifeskim:mentions | umls-concept:C1704711 | lld:lifeskim |
pubmed-article:16096320 | lifeskim:mentions | umls-concept:C2348867 | lld:lifeskim |
pubmed-article:16096320 | lifeskim:mentions | umls-concept:C0165919 | lld:lifeskim |
pubmed-article:16096320 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16096320 | pubmed:dateCreated | 2005-9-28 | lld:pubmed |
pubmed-article:16096320 | pubmed:abstractText | To determine the global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae isolated from patients with community-acquired respiratory tract infection during the first 4 years of the PROTEKT study (1999-2003). To investigate the activities of commonly used antibiotics against these isolates. | lld:pubmed |
pubmed-article:16096320 | pubmed:language | eng | lld:pubmed |
pubmed-article:16096320 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16096320 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16096320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16096320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16096320 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16096320 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16096320 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16096320 | pubmed:issn | 0305-7453 | lld:pubmed |
pubmed-article:16096320 | pubmed:author | pubmed-author:FarrellD JDJ | lld:pubmed |
pubmed-article:16096320 | pubmed:author | pubmed-author:BakkerSS | lld:pubmed |
pubmed-article:16096320 | pubmed:author | pubmed-author:FelminghamDD | lld:pubmed |
pubmed-article:16096320 | pubmed:author | pubmed-author:MorrisseyII | lld:pubmed |
pubmed-article:16096320 | pubmed:author | pubmed-author:BuckridgeSS | lld:pubmed |
pubmed-article:16096320 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16096320 | pubmed:volume | 56 | lld:pubmed |
pubmed-article:16096320 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16096320 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16096320 | pubmed:pagination | 773-6 | lld:pubmed |
pubmed-article:16096320 | pubmed:dateRevised | 2008-8-22 | lld:pubmed |
pubmed-article:16096320 | pubmed:meshHeading | pubmed-meshheading:16096320... | lld:pubmed |
pubmed-article:16096320 | pubmed:meshHeading | pubmed-meshheading:16096320... | lld:pubmed |
pubmed-article:16096320 | pubmed:meshHeading | pubmed-meshheading:16096320... | lld:pubmed |
pubmed-article:16096320 | pubmed:meshHeading | pubmed-meshheading:16096320... | lld:pubmed |
pubmed-article:16096320 | pubmed:meshHeading | pubmed-meshheading:16096320... | lld:pubmed |
pubmed-article:16096320 | pubmed:meshHeading | pubmed-meshheading:16096320... | lld:pubmed |
pubmed-article:16096320 | pubmed:meshHeading | pubmed-meshheading:16096320... | lld:pubmed |
pubmed-article:16096320 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16096320 | pubmed:articleTitle | Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae. | lld:pubmed |
pubmed-article:16096320 | pubmed:affiliation | GR Micro Limited, 7-9 William Road, London NW1 3ER, UK. D.Farrell@grmicro.co.uk | lld:pubmed |
pubmed-article:16096320 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16096320 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16096320 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16096320 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16096320 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16096320 | lld:pubmed |